approval · primary record
OMALIZUMAB-IGEC
FDA · BLA · 2025-12-01
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-12-01 |
| Brand | OMLYCLO |
| Sponsor | CELLTRION INC |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:30:05.546Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:OMALIZUMAB-IGEC:2025-12-01
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.